Bioactive Wound Management Market Overview, Growth, Trends, Analysis, Research Report (2021-2031)

The Bioactive Wound Management Market Size was estimated to be US$ 1.99 billion in 2021 and US$ XX billion in 2023 and is expected to reach US$ 4.28 billion by 2031; it is estimated to record a CAGR of 8.3% by 2031. 3D Printing in Wound Care Management is likely to remain a key Bioactive Wound Management Market Trend.  

Bioactive Wound Management Market Analysis

The rise in the incidence of chronic injuries and an increased number of surgical procedures are contributing to the bioactive wound management market growth. Globally, the prevalence of surgical site infection is anticipated to rise owing to the growing number of surgeries. An increase in the number of surgical procedures globally is due to the rising prevalence of various chronic diseases. According to data provided by the National Institutes of Health (NIH), ~20 million major surgeries are carried out each year in Europe. According to the Dubai Health Authority (DHA), ~159,000 surgeries were performed in Dubai in 2021. Per the same source, the number of people seeking cosmetic surgeries in Dubai doubled from 223,507 in 2020 to 583,909 in 2022. Bioactive wound management products enable rapid healing of surgical site infection; the increasing number of surgical procedures is projected to surge the demand for these products in the near future.    

Bioactive Wound Management Market Overview

The North American region held the largest share of the bioactive wound management market. The significant rise in investments for the development of novel products as well as the presence of top pharmaceutical giants in the region is likely to be responsible for the dominance of the market. The North American players have a global network of distribution centers that helps the companies to reach multiple locations across the world. The Asia Pacific region is projected to be the fastest-growing region among all other regions. The growth of the bioactive wound management market is expected to be fastest in countries such as India, China, and Australia. The growth of the market in these countries is expected to be fastest due to the rising prevalence of chronic wounds, increasing diabetic and aging population, and improving healthcare facilities. Furthermore, the presence of active wound care management bodies in the region is offering lucrative opportunities for the growth of the market.   

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Bioactive Wound Management Market: Strategic Insights

Bioactive Wound Management Market

• 
  CAGR (2023 - 2031)

  8.3%
• Market Size 2021
  US$ 1.99 Billion
• Market Size 2031
  US$ 4.28 Billion

Market Dynamics

GROWTH DRIVERS

• The rise in the incidence of chronic injuries and an increased number of surgical procedures are contributing to the bioactive wound management market growth. Globally, the prevalence of surgical site infection is anticipated to rise owing to the growing number of surgeries. An increase in the number of surgical procedures in globally is due to the rising prevalence of various chronic diseases. According to data provided by the National Institutes of Health (NIH), ~20 million major surgeries are carried out each year in Europe. According to Dubai Health Authority (DHA), ~159,000 surgeries were performed in Dubai in 2021. Per the same source, the number of people seeking cosmetic surgeries in Dubai doubled from 223,507 in 2020 to 583,909 in 2022. Bioactive wound management products enable rapid healing of surgical site infection; the increasing number of surgical procedures is projected to surge the demand for these products in the near future

FUTURE TRENDS

• "Chronic wounds can cause difficulties for surgeons in effectively managing such wounds, leading to further complications. With an growing number of patients suffering from chronic wounds, there is a growing need for a systematic approach to treatment, which has driven the adoption of evidence-based care. Research and clinical trials have shown that the use of bioactive wound care products can improve the healing of moist wounds. Government bodies and research universities play an active role in promoting advancements in wound care, and several research organizations are dedicated to developing advanced wound care products. This is likely to create growth opportunities during the forecast period. Some instances in this regard are mentioned below:• In July 2023, Researchers from Queen's University Belfast have developed a new treatment for diabetic foot ulcers (DFUs) using a 3D printed bandage known as a scaffold. This innovative technology combines lipid nanoparticles and hydrogels to create personalized skin-like scaffolds that release both a bulk and sustained release of antibiotic-loaded molecules to treat DFUs. This new discovery has the potential to significantly improve the treatment of diabetic ulcers. • In June 2023, researchers from the University of Birmingham showcased a new technique that demonstrated how silver could retain its antimicrobial properties for longer periods of time when impregnated into 'bioactive glass'. This combination was found to deliver more effective and long-lasting antimicrobial wound protection when compared to more conventional alternatives. Bioactive glasses-a unique class of synthetic biomaterials that have been made from silicone and have been used for several years in bone grafting. "

OPPORTUNITIES

• "Several cost-effective wound-healing technologies are being developed to meet the increasing demand. The developments in wound management have led to a shift from simple dressings to advanced wound care products. Advanced wound dressings have been designed to create a moist environment that promotes healing. Keratin-based wound care products are often used in conjunction with these dressings to aid in wound re-epithelialisation. These products facilitate faster healing by being absorbed into the wounds, which eliminates the need to frequently change the dressing.. Furthermore, the usage of biologic scaffold materials including an intact extracellular matrix (ECM) or individual components of the ECM provide new therapeutic options that focus upon the wound microenvironment and facilitate rapid restoration of skin. A few advancements in wound care products are mentioned below:• Integra Life Sciences offers a wide range of wound management products such as Integra Bilayer Wound Matrix, Integra Meshed Bilayer Wound Matrix, and Integra Flowable Wound Matrix. These are composite of cross-linked bovine collagen, glycosaminoglycan, and silicone covering. These are used in the management of partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds. • Matristem (ACell Inc.) is a natural ECM scaffold consisting of noncross-linked porcine UBM-ECM. The primary advantage of UBM-ECM over other natural ECM products is that it retains the urinary bladder’s basement membrane component on one surface of the biologic scaffold. The basement membrane functions to anchor epithelial tissues to the ECM in organs such as the skin and blood vessels"

Key Players

• MiMedx
• Integra LifeSciences
• Organogenesis
• Tissue Regenix Group Plc
• Coloplast
• Hartmann plc
• Covalon Technologies Ltd.
• ConvaTec
• ETS Wound Care, LLC.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Product

• Bioengineered Skin Substitutes
• Collagen-based Dressing
• Antimicrobial Dressings
• Alginates
• Hydrocolloids

Application

• Pressure Ulcers
• Diabetic Foot Ulcers
• Venous Leg Ulcers
• Burn Wounds
• Surgical Wounds

End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Bioactive Wound Management Market Drivers and Opportunities

Innovation in Advanced Wound Care Products to Favor Market

Several cost-effective wound-healing technologies are being developed to meet the increasing demand. The developments in wound management have led to a shift from simple dressings to advanced wound care products. Advanced wound dressings have been designed to create a moist environment that promotes healing. Keratin-based wound care products are often used in conjunction with these dressings to aid in wound re-epithelialization. These products facilitate faster healing by being absorbed into the wounds, which eliminates the need to frequently change the dressing. Furthermore, the usage of biological scaffold materials including an intact extracellular matrix (ECM) or individual components of the ECM provides new therapeutic options that focus on the wound microenvironment and facilitate rapid restoration of skin.  

A few advancements in wound care products are mentioned below:

•Integra Life Sciences offers a wide range of wound management products such as Integra Bilayer Wound Matrix, Integra Meshed Bilayer Wound Matrix, and Integra Flowable Wound Matrix. These are composite of cross-linked bovine collagen, glycosaminoglycan, and silicone covering. These are used in the management of partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, and surgical wounds.  

•Matristem (ACell Inc.) is a natural ECM scaffold consisting of non-cross-linked porcine UBM-ECM. The primary advantage of UBM-ECM over other natural ECM products is that it retains the urinary bladder’s basement membrane component on one surface of the biological scaffold. The basement membrane functions to anchor epithelial tissues to the ECM in organs such as the skin and blood vessels.

Increasing Research Activities to Introduce Novel Wound Treatments – An Opportunity

Chronic wounds can cause difficulties for surgeons in effectively managing such wounds, leading to further complications. With a growing number of patients suffering from chronic wounds, there is a growing need for a systematic approach to treatment, which has driven the adoption of evidence-based care. Research and clinical trials have shown that the use of bioactive wound care products can improve the healing of moist wounds. Government bodies and research universities play an active role in promoting advancements in wound care, and several research organizations are dedicated to developing advanced wound care products. This is likely to create growth opportunities during the forecast period.

Some instances in this regard are mentioned below:

• In July 2023, Researchers from Queen's University Belfast developed a new treatment for diabetic foot ulcers (DFUs) using a 3D-printed bandage known as a scaffold. This innovative technology combines lipid nanoparticles and hydrogels to create personalized skin-like scaffolds that release both a bulk and sustained release of antibiotic-loaded molecules to treat DFUs. This discovery has the potential to significantly improve the treatment of diabetic ulcers.
• In June 2023, researchers from the University of Birmingham showcased a new technique that demonstrated how silver could retain its antimicrobial properties for longer periods of time when impregnated into 'bioactive glass'. This combination was found to deliver more effective and long-lasting antimicrobial wound protection when compared to more conventional alternatives. Bioactive glasses-a unique class of synthetic biomaterials that have been made from silicone and have been used for several years in bone grafting.

Bioactive Wound Management Market Report Segmentation Analysis

Key segments that contributed to the derivation of the bioactive wound management market analysis are product, application, and end user.

• Based on product, the bioactive wound management market is segmented into bioengineered skin substitutes, collagen-based dressing, antimicrobial dressings, alginates, and hydrocolloids. The alginates segment held the largest market share in 2023.
• By application, the market is segmented into pressure ulcers, diabetic foot ulcers, venous leg ulcers, burn wounds, and surgical wounds. The burn wounds segment held the largest share of the market in 2023.
• In terms of end users, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment dominated the market in 2023.

Bioactive Wound Management Market Share Analysis by Geography

The geographic scope of the bioactive wound management market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America. North America has dominated the bioactive wound management market. The bioactive wound management market in the US is expected to be the largest and fastest-growing due to various factors. Few of the driving factors include the presence of various medical device manufacturers producing bioactive wound management devices and products and, support of the government by providing advanced tools, technology, and experience for optimal wound care.  The companies in the US are increasing their presence by following organic and inorganic strategies. For instance, in October 2021, Medline Industries announced an investment of US$ 77.5 million to build a new distribution center in Kansas. Therefore, the increasing need in the US for wound dressing indicates a substantial opportunity for the key players to develop wound care management with innovative products. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.  

Bioactive Wound Management Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Bioactive Wound Management Market News and Recent Developments

The bioactive wound management market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for bioactive wound management:

• In July 2022, Smith+Nephew introduced the WOUND COMPASS Clinical Support App. This app is a comprehensive digital tool for healthcare professionals designed to assist in wound assessment and decision-making, with the aim of reducing practice variation. (Source: Smith+Nephew, 2022)
• In June 2022, Medline launched its Optifoam Gentle EX Foam Dressing. The product is designed to help displace pressure when used with pressure injury prevention protocol. The product features five unique layers to help absorb shear force and friction and manage moisture. (Source: Medline, 2022)
• In January 2022, Convatec acquired Triad Life Sciences Inc. The acquisition strengthens Convatec’s Advanced Wound Care position in the US (Focus) and secures access to a complementary and innovative technology platform (Innovation) that enhances advanced wound management and patient outcomes. (Source: Convatec, 2022)  
• In February 2021, AxioBiosolutions received CE certification from Europe for its MaxioCel line of next-generation advanced wound care products. This regulatory approval allows Axio to enter the fast-growing USD14 billion advanced wound care market globally. (Source: AxioBiosolutions, 2021)   

Bioactive Wound Management Market Report Coverage and Deliverables

The “Bioactive Wound Management Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles  
• Smith+Nephew